Quantcast

Latest Duloxetine Stories

2014-07-15 23:07:22

MedicationDiscountCard.com offers discounts of 10-75% on fibromyalgia treatments. Margate, NJ (PRWEB) July 15, 2014 Recent surveys show that about 2% of Americans currently suffer from fibromyalgia. Most of these are women, with about 20% of new diagnoses being men or children. Fibromyalgia can present itself with many different symptoms, including sensitivity to light, odors, and noise, or more acute symptoms like facial pain and TMJ (lockjaw). On average, patients dealing with...

2014-06-26 08:27:08

Top-line results anticipated by end-of-year RALEIGH, N.C., June 26, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it has completed enrollment of all patients required for its initial Phase 3 study of Clonidine Topical Gel for the treatment of painful diabetic neuropathy (PDN). http://photos.prnewswire.com/prnvar/20110217/CL49801LOGO The Phase 3 trial is a multicenter, randomized, double-blind, placebo-controlled study to determine the...

2014-06-12 16:25:56

BOCA RATON, Fla., June 12, 2014 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Duloxetine Delayed-release Capsules. The U.S. Food and Drug Administration granted final approval for the Abbreviated New Drug Application (ANDA), which is being manufactured and supplied by its parent company, Laboratorios Dr. Esteve, S.A. Barcelona, Spain, and will be available in 20mg, 30mg and 60mg strengths. Duloxetine Delayed-release Capsules are AB rated to...

2014-05-06 08:33:33

Faster than projected enrollment moves anticipated interim analysis up to third quarter 2014 RALEIGH, N.C., May 6, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it has randomized more than half of the planned number of patients required for its ongoing initial Phase 3 study of Clonidine Topical Gel, BDSI's proposed treatment for painful diabetic neuropathy (PDN). The intent of the study will be to demonstrate the efficacy and safety of...

2014-04-21 08:26:01

GOLDEN, Colo., April 21, 2014 /PRNewswire/ -- A survey of 1,339 people with fibromyalgia conducted by The National Pain Foundation and NationalPainReport.com, revealed that those who have used marijuana to treat their symptoms find it significantly more effective than any of the three drugs approved by the Food and Drug Administration to treat the disorder. Photo - http://photos.prnewswire.com/prnh/20140418/76548 Photo - http://photos.prnewswire.com/prnh/20140418/76547 The three drugs...

2014-04-03 08:28:55

Product has fast track designation by FDA RALEIGH, N.C., April 3, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced today the enrollment of the first patient in the RHAPSODY Study, a Phase 3 clinical trial of Clonidine Topical Gel for the treatment of painful diabetic neuropathy. The Phase 3 trial is a multicenter, randomized, double blind, placebo controlled study to determine the efficacy and safety of Clonidine Topical Gel in the treatment...

2014-03-25 00:23:16

DUBLIN, March 25, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/rt6msb/investigation) has announced the addition of the "Investigation Report on China Duloxetine Market" [http://www.researchandmarkets.com/research/rt6msb/investigation ] report to their offering. <start_newscom> (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Depression is a common mood disorder that belongs to high-incidence mental...

2014-03-04 23:02:22

The Osteoarthritis Research Society International (OARSI) releases new evidence-based guidelines for the non-surgical treatment of osteoarthritis of the knee that, for the first time, are targeted to differing patient characteristics. Mount Laurel, NJ (PRWEB) March 04, 2014 The Osteoarthritis Research Society International (OARSI) releases new evidence-based guidelines for the non-surgical treatment of osteoarthritis of the knee that, for the first time, are targeted to differing patient...

2014-02-14 16:25:45

DUBLIN, February 14, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/pdhgfs/pain_management) has announced the addition of the "Pain Management Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast to 2018" [http://www.researchandmarkets.com/research/pdhgfs/pain_management ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The global pain management...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related